Search research articles
Contact Us
Filters
Showing results (1-10 of 78) with videos related to
Page
of 8
Sort By:
Rheumatology (Oxford, England)
|
November 17, 2011
Economic studies in rheumatology: data, perspectives, challenges
Gisela Kobelt
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
February 24, 2007
Costs and quality of life for patients with multiple sclerosis in Belgium
Gisela Kobelt
Expert Review of Neurotherapeutics
|
December 3, 2013
Health economic evaluation: why? When? How?
Gisela Kobelt
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 17, 2014
Treating to target with etanercept in rheumatoid arthritis: cost-effectiveness of dose reductions when remission is achieved
Gisela Kobelt
Journal of Glaucoma
|
December 17, 2002
Health economics, economic evaluation, and glaucoma
Gisela Kobelt
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
March 9, 2005
Economic evidence in multiple sclerosis: a review
Gisela Kobelt
Annals of the Rheumatic Diseases
|
November 21, 2007
Thoughts on health economics in rheumatoid arthritis
Gisela Kobelt
Clinical Neurology and Neurosurgery
|
July 20, 2002
Quality of life and cost of multiple sclerosis
Carolin Miltenburger, Gisela Kobelt
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 24, 2017
Editorial
Alan Thompson, Gisela Kobelt
Multiple Sclerosis and Related Disorders
|
October 23, 2017
Tackling comorbidity in multiple sclerosis
Gisela Kobelt, Gavin Giovannoni
Page
of 8
Search research articles
Search
Showing results (1-10 of 78) with videos related to
Sort By:
Page
of 8
Rheumatology (Oxford, England)
|
November 17, 2011
Economic studies in rheumatology: data, perspectives, challenges
Gisela Kobelt
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
February 24, 2007
Costs and quality of life for patients with multiple sclerosis in Belgium
Gisela Kobelt
Expert Review of Neurotherapeutics
|
December 3, 2013
Health economic evaluation: why? When? How?
Gisela Kobelt
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 17, 2014
Treating to target with etanercept in rheumatoid arthritis: cost-effectiveness of dose reductions when remission is achieved
Gisela Kobelt
Journal of Glaucoma
|
December 17, 2002
Health economics, economic evaluation, and glaucoma
Gisela Kobelt
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
March 9, 2005
Economic evidence in multiple sclerosis: a review
Gisela Kobelt
Annals of the Rheumatic Diseases
|
November 21, 2007
Thoughts on health economics in rheumatoid arthritis
Gisela Kobelt
Clinical Neurology and Neurosurgery
|
July 20, 2002
Quality of life and cost of multiple sclerosis
Carolin Miltenburger, Gisela Kobelt
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 24, 2017
Editorial
Alan Thompson, Gisela Kobelt
Multiple Sclerosis and Related Disorders
|
October 23, 2017
Tackling comorbidity in multiple sclerosis
Gisela Kobelt, Gavin Giovannoni
Page
of 8